Astellas

Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Fierce Biotech
Mon, 12/28/20 - 10:59 am
Audentes
Astellas
FDA
clinical trials
AT132
gene therapy
X-linked myotubular myopathy
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Pharmaceutical Business Review
Sun, 11/29/20 - 02:10 pm
Astellas
FibroGen
Japan
Evrenzo
chronic kidney disease
Fancy a Black Friday R&D deal? Astellas has you covered
Fierce Biotech
Wed, 11/25/20 - 10:34 am
Astellas
R&D
$200M investment to advance clinical programs for Ambrx
MedCity News
Mon, 11/23/20 - 10:18 pm
Ambrx
oncology
Astellas
BeiGene
Bristol-Myers Squibb
In early blow to Kenji Yasukawa's R&D revamp, Astellas drops out of the TIGIT race without explanation
Endpoints
Fri, 10/30/20 - 10:17 am
Astellas
earnings
anti-TIGIT
R&D
A Year After Partnering with iota, Astellas Snaps Up the Company
BioSpace
Thu, 10/15/20 - 12:27 pm
Astellas
iota Biosciences
bioelectronics
Seagen, Astellas report positive results from PADCEV phase 2 trial in advanced urothelial cancer
Pharmaceutical Business Review
Tue, 10/13/20 - 11:08 am
Seagen
Astellas
clinical trials
EV-201
urothelial cancer
Seattle Genetics stays step ahead of rivals with bladder cancer data
BioPharma Dive
Sat, 09/19/20 - 09:04 pm
Seattle Genetics
Astellas
Padcev
bladder cancer
clinical trials
ESMO
Astellas puts health inequality front and center in cancer innovation challenge's 5th year
Fierce Pharma
Tue, 09/1/20 - 10:34 pm
Astellas
oncology
innovation
innovation challenges
Astellas' Audentes reports 3rd death in gene therapy trial
Fierce Biotech
Fri, 08/21/20 - 12:11 pm
Audentes Therapeutics
Astellas
clinical trials
gene therapy
patient deaths
AT132
GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival
Pharmaforum
Mon, 06/29/20 - 06:21 pm
GSK
anemia
chronic kidney disease
daprodustat
Japan
Astellas
Kyowa Kirin
With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity: panel
Fierce Pharma
Wed, 06/24/20 - 11:21 pm
cell therapy
gene therapy
Novartis
Kite Pharma
Biomarin
Astellas
Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp
BioSpace
Mon, 06/8/20 - 11:36 pm
Astellas
clinical trials
roxadustat
Amgen
Aranesp
anemia
chronic kidney disease
ASCO: Pfizer, Astellas show Xtandi helps early prostate cancer patients live longer
Fierce Pharma
Thu, 05/14/20 - 10:15 am
ASCO 2020
Pfizer
Astellas
Xtandi
castration-resistant prostate cancer
Harvard pens Astellas research deal, vowing to push on despite pandemic
Fierce Biotech
Tue, 04/28/20 - 11:48 pm
Harvard
Astellas
R&D
COVID-19
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
CytomX pens $1.6B Astellas biobucks pact for T-cell R&D
Fierce Biotech
Tue, 03/24/20 - 10:22 am
Astellas
CytomX
R&D
Pharma New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes
Fierce Pharma
Fri, 02/14/20 - 05:07 pm
Astellas
Seattle Genetics
Padcev
advanced bladder cancer
bladder cancer
Pfizer and Astellas Report Positive OS Data in Prostate Cancer Study
BioSpace
Tue, 02/11/20 - 11:45 pm
Pfizer
Astellas
prostate cancer
metastatic castration-resistant prostate cancer
Xtandi
Seattle Genetics, Astellas Says 73% Of Bladder Cancer Patients On Padcev Had Confirmed Tumor Response
Reuters
Tue, 02/11/20 - 10:46 am
Seattle Genetics
Astellas
bladder cancer
Padcev

Pages